Cointime

Enable Biosciences

company

About

Enable Biosciences is a biotech company.

Highlights

Total Funding Amount
$4.15M
Funding Rounds
4
Investors
2
Employee Profiles
1

Details

Last Funding Type
Grant
Last Funding Money Raised
$1.50M
Industries
Biotechnology,Life Science
Founded date
Jan 1, 2015
Number Of Employee
11 - 50
Operating Status
Active
Legal Name
Enable Biosciences

Enable Biosciences is a biotech company making ultrasensitive tests for hiv, type 1 diabetes, and many other diseases. They develop ultrasensitive immunoassays that permit early detection and treatment of autoimmune and infectious diseases.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
4
$4.15M
Enable Biosciences has raised a total of $4.15M in funding over 2 rounds. Their latest funding was raised on Nov 19, 2019 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 19, 2019 Grant $1.48M 1 National Institutes of Health — Detail
Jul 31, 2018 Grant $1.50M 1 National Institutes of Health — Detail
Mar 8, 2018 Grant $899.62K 1 National Science Foundation — Detail
Jun 22, 2016 Grant $269.77K 1 National Science Foundation — Detail

Investors

Number of Lead Investors
Number of Investors
4
2
Enable Biosciences is funded by 2 investors. National Institutes of Health and National Science Foundation are the most recent investors.
Investor Name Lead Investor Funding Round
National Institutes of Health Yes Grant
National Science Foundation Yes Grant

Employee Profiles

Number of Employee Profiles
1
Enable Biosciences has 1 current employee profiles, including Executive DAVID SEFTEL
DAVID SEFTEL
Executive
Cointime
Chủ Đề
Công Ty